Statera Biopharma, Inc. Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31)
Statera Biopharma, Inc. reported Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31) of $1.72 million for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-07.
Discontinued › Notes › Derivative Instruments and Hedging Activities
us-gaap:IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments · last filed 2012-05-07
- Statera Biopharma, Inc. increase (decrease) in fair value of derivative instruments, not designated as hedging instruments (deprecated 2013-01-31) for the quarter ending 2012-03-31 was $1.72M.
- Statera Biopharma, Inc. increase (decrease) in fair value of derivative instruments, not designated as hedging instruments (deprecated 2013-01-31) for the quarter ending 2011-03-31 was -$714.95K.
- Statera Biopharma, Inc. increase (decrease) in fair value of derivative instruments, not designated as hedging instruments (deprecated 2013-01-31) for fiscal 2011 was $19.82M.
- Statera Biopharma, Inc. increase (decrease) in fair value of derivative instruments, not designated as hedging instruments (deprecated 2013-01-31) for fiscal 2010 was -$16.01M.
- Statera Biopharma, Inc. increase (decrease) in fair value of derivative instruments, not designated as hedging instruments (deprecated 2013-01-31) for fiscal 2009 was -$6.27M.
| Period end | Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31) 3 month | Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31) 12 month |
|---|---|---|
| 2012-03-31 | $1.72M 10-Q · filed 2012-05-07 | |
| 2011-12-31 | $19.82M 10-K · filed 2012-03-13 | |
| 2011-03-31 | -$714.95K 10-Q · filed 2012-05-07 | |
| 2010-12-31 | -$16.01M 10-K · filed 2012-03-13 | |
| 2009-12-31 | -$6.27M 10-K · filed 2012-03-13 |